Evidence map›Paper›PMID 30322215›Full record

ReviewInternational journal of molecular sciences2018

Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?

Mélanie Lambert, Véronique Capuano, Andrea Olschewski, Jessica Sabourin, Chandran Nagaraj, Barbara Girerd, Jason Weatherald, Marc Humbert, Fabrice Antigny

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Up-regulated expression of two-pore domain KFrontiers in cardiovascular medicine · 2024
    Article
  10. Review
  11. Review
  12. Review
  13. Pulmonary Vascular Remodeling in Pulmonary Hypertension.Journal of personalized medicine · 2023
    Review
  14. Review
  15. Targeting ATP-Sensitive KAmerican journal of respiratory cell and molecular biology · 2022
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Mélanie LambertUniv. Paris-Sud, Faculté de Médecine, 94270 Kremlin-Bicêtre, France. melanie.lambert91@hotmail.fr.
Véronique CapuanoUniv. Paris-Sud, Faculté de Médecine, 94270 Kremlin-Bicêtre, France. veronique.capuano@u-psud.fr.
Andrea OlschewskiLudwig Boltzmann Institute for Lung Vascular Research, Stiftingtalstrasse 24, Graz 8010, Austria. andrea.olschewski@lvr.lbg.ac.at.
Jessica SabourinSignalisation et Physiopathologie Cardiovasculaire, UMRS 1180, Univ. Paris-Sud, INSERM, Université Paris-Saclay, 92296 Châtenay-Malabry, France. jessica.sabourin@u-psud.fr.
Chandran NagarajLudwig Boltzmann Institute for Lung Vascular Research, Stiftingtalstrasse 24, Graz 8010, Austria. nagaraj.chandran@lvr.lbg.ac.at.
Barbara GirerdUniv. Paris-Sud, Faculté de Médecine, 94270 Kremlin-Bicêtre, France. barbara.girerd19@gmail.com.
Jason WeatheraldUniv. Paris-Sud, Faculté de Médecine, 94270 Kremlin-Bicêtre, France. jweatherald@gmail.com.
Marc HumbertUniv. Paris-Sud, Faculté de Médecine, 94270 Kremlin-Bicêtre, France. mjc.humbert@gmail.com.ORCID 0000-0003-0703-2892
Fabrice AntignyUniv. Paris-Sud, Faculté de Médecine, 94270 Kremlin-Bicêtre, France. fabrice.antigny@u-psud.fr.
Université Paris-Sud · FRLudwig Boltzmann Institute for Lung Vascular Research · ATMedical University of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary arterial hypertension (PAH) is a multifactorial and severe disease without curative therapies. PAH pathobiology involves altered pulmonary arterial tone, endothelial dysfunction, distal pulmonary vessel remodeling, and inflammation, which could all depend on ion channel activities (K⁺, Ca

Indexed as

AnimalsAntihypertensive AgentsGene Expression RegulationHumansHypertension, PulmonaryIon ChannelsAntihypertensive AgentsIon ChannelsK+ channelsKCNK3Na+ channelsOraiPAHpulmonary hypertensionTMEM16ATRPC

Identifiers

PMID30322215
PMCPMC6214085
OpenAlexW2897065794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.